Belgium
Apax acquires BNP Paribas Personal Finance Belgium
Apax has agreed to acquire BNP Paribas Personal Finance Belgium from BNP Paribas.
Waterland ups stake in Arseus
Waterland Private Equity has increased its stake in medical supplies and services company Arseus.
Apax Patners sells remaining stake in Galapagos
Apax Partners' funds and listed vehicle Altamir Amboise has sold its 5.4% remaining stake in listed biotechnology company Galapagos.
Vesalius and LRM back Complix
Vesalius Biocapital and LRM have backed Belgian pharmaceutical company, Complix NV.
BNP Paribas Private Equity appoints two new investment directors
Alexandra Dupont and Nicolas Schwindenhammer have been appointed as investment directors for BNP Paribas Private Equity.
AXA Private Equity's Sfinc acquires JADICO
AXA Private Equity's portfolio company Sfinc, a Belgian manufacturer of ingredients for the food processing industry, has acquired Netherlands-based JADICO.
KBC cancels plans to sell private equity unit
KBC Group has abandoned plans to sell its private equity division, according to reports.
The Riverside Company appoints Vincent Daelemans
The Riverside Company has strengthened its European team with the appointment of Vincent Daelemans, who will take up the new position as vice president of origination for Benelux and France.
Summit takes majority stake in Ogone
Summit Partners is to acquire a majority stake in online payment processing company Ogone SA/NV; financial terms of the transaction were not disclosed.
Stonefund changes office
Belgium-based investor Stonefund has relocated to new offices.
CVC mulls Belgian Post IPO
European investor CVC Capital Partners is said to be eyeing the listing of Belgian mail services De Post – Le Poste.
NPM agrees deal for Punch Graphix
Belgian private equity firm NPM and Punch International, have agreed to the sale of Punch's subsidiary, Punch Graphix NV.
Benelux unquote" April 2010
If there is one rule that prevails over private equity commentary nowadays, it is that determining any long term trend remains extremely difficult; such is the volatility in the market. The effect on the retail sector is particularly evident. KKR-backed...
The beauty of small things
If there is one rule that prevails over private equity commentary nowadays, it is that determining any long term trend remains extremely difficult, such is the volatility in the market.
AXA PE to bid for KBC's private equity division
According to reports, AXA Private Equity, alongside Belgian investment group Sofina, is in the bidding process for the acquisition of KBC Private Equity.
Gimv and Capricorn invest €24m in Punch Powertrain
Gimv and Capricorn have jointly invested €24m in automotive component manufacturer Punch Powertrain.
Gimv-XL closes on €609m
European investment company Gimv has announced the final closing of its latest vehicle Gimv-XL fund at €609m.
Venture away
Let’s face it, European venture has not got the best standing with global LPs – a result of the tech bubble bursting a decade ago. Although the market should be defined as maturing by now, such generalisations are not easily applicable to a continent...
Fundraising set for 2010 uptick after defiant year
According to figures to be published in the upcoming European Fundraising Review 2010, fundraising in the Benelux region has remained resilient in 2009 in spite of the downturn.
Alvarez & Marsal expand services across Benelux
International bankruptcy advisory firm Alvarez & Marsal (A&M), appoints two to its Benelux practice as it broadens its service offering across the region.
Q&A: Fundraising in 2010 and beyond
Charlie Jolly principal at Matrix talks to Francinia Protti-Alvarez about recent fundraising trends and implications for the future.
Q&A: Early-stage evolution
Bart Diels, partner at Belgian investor Gimv, speaks to Francinia Protti-Alvarez about how the venture market in the Benelux region has adapted to the changing economic climate.
Salans opens office in Brussels
International law firm Salans has opened an office in Brussels which will commence operating as of 1 March.